Skip to main content
logo
Rigel Pharmaceuticals, Inc. (RIGL)
NASDAQ: RIGL · Real-Time Price · USD
30.25
-0.05 (-0.17%)
At close: Jun 4, 2026, 4:00 PM EDT
30.36
+0.11 (0.36%)
After-hours: Jun 4, 2026, 6:09 PM EDT

Rigel Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Cap
560784298253260455
Market Cap Growth
58.96%163.27%17.51%-2.54%-42.80%-23.26%
Enterprise Value
458.72652.18272.97249.22242.31350.45
Last Close Price
30.2542.8316.8214.5015.0026.50
PE Ratio
1.602.2016.99---
Forward PE
7.7610.4917.39---
PS Ratio
1.872.661.662.172.163.05
PB Ratio
1.402.0090.60-8.85-19.1014.97
P/TBV Ratio
1.452.0690.48-8.81-18.7814.88
P/FCF Ratio
7.0610.379.48--86.60
P/OCF Ratio
7.0610.379.47--77.36
EV/Sales Ratio
1.532.221.522.132.022.35
EV/EBITDA Ratio
3.615.1010.33---
EV/EBIT Ratio
3.685.2011.28---
EV/FCF Ratio
5.798.628.68--66.74
Debt / Equity Ratio
0.040.0615.94-1.84-2.970.68
Debt / EBITDA Ratio
0.360.422.27---
Debt / FCF Ratio
0.580.711.91--5.82
Net Debt / Equity Ratio
-0.25-0.26-5.28-0.131.22-3.11
Net Debt / EBITDA Ratio
-0.79-0.79-0.66-0.190.318.33
Net Debt / FCF Ratio
-1.27-1.34-0.55-0.630.22-17.98
Asset Turnover
0.590.871.280.930.801.07
Inventory Turnover
1.712.243.240.970.220.26
Quick Ratio
2.202.081.881.641.512.21
Current Ratio
2.622.422.131.861.782.43
Return on Equity (ROE)
92.05%185.94%-137.92%118.75%-699.04%-55.63%
Return on Assets (ROA)
73.07%111.57%16.38%-16.29%-36.84%-9.31%
Return on Invested Capital (ROIC)
110.93%189.26%42.09%-48.45%-131.03%-32.41%
Return on Capital Employed (ROCE)
30.04%48.72%29.39%-30.81%-64.28%-14.42%
Earnings Yield
65.08%45.48%5.89%---
FCF Yield
14.16%9.65%10.55%--1.15%
Buyback Yield / Dilution
-7.67%-6.52%-1.64%-2.06%0.00%-1.03%
Total Shareholder Return
-7.67%-6.52%-1.64%-2.06%0.00%-1.03%
SEC Filings: 10-K · 10-Q